Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC).

NCT05760313 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05760313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05760313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC).
Lead sponsor
AbbVie
Phase
Phase 2
Overall status
Completed
Start date
April 27, 2023
Completion date
June 9, 2025
Enrollment
19 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

functional constipation